GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » KPC Pharmaceuticals Inc (SHSE:600422) » Definitions » Shiller PE Ratio

KPC Pharmaceuticals (SHSE:600422) Shiller PE Ratio : 28.95 (As of Dec. 12, 2024)


View and export this data going back to 2000. Start your Free Trial

What is KPC Pharmaceuticals Shiller PE Ratio?

As of today (2024-12-12), KPC Pharmaceuticals's current share price is ¥16.79. KPC Pharmaceuticals's E10 for the quarter that ended in Sep. 2024 was ¥0.58. KPC Pharmaceuticals's Shiller PE Ratio for today is 28.95.

The historical rank and industry rank for KPC Pharmaceuticals's Shiller PE Ratio or its related term are showing as below:

SHSE:600422' s Shiller PE Ratio Range Over the Past 10 Years
Min: 16.18   Med: 28.96   Max: 147.24
Current: 28.95

During the past years, KPC Pharmaceuticals's highest Shiller PE Ratio was 147.24. The lowest was 16.18. And the median was 28.96.

SHSE:600422's Shiller PE Ratio is ranked worse than
52.9% of 465 companies
in the Drug Manufacturers industry
Industry Median: 26.8 vs SHSE:600422: 28.95

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

KPC Pharmaceuticals's adjusted earnings per share data for the three months ended in Sep. 2024 was ¥0.212. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ¥0.58 for the trailing ten years ended in Sep. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


KPC Pharmaceuticals Shiller PE Ratio Historical Data

The historical data trend for KPC Pharmaceuticals's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

KPC Pharmaceuticals Shiller PE Ratio Chart

KPC Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 25.06 18.32 21.20 25.82 37.24

KPC Pharmaceuticals Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 33.76 37.24 37.79 31.57 27.23

Competitive Comparison of KPC Pharmaceuticals's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, KPC Pharmaceuticals's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


KPC Pharmaceuticals's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, KPC Pharmaceuticals's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where KPC Pharmaceuticals's Shiller PE Ratio falls into.



KPC Pharmaceuticals Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

KPC Pharmaceuticals's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=16.79/0.58
=28.95

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

KPC Pharmaceuticals's E10 for the quarter that ended in Sep. 2024 is calculated as:

For example, KPC Pharmaceuticals's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=0.212/115.7848*115.7848
=0.212

Current CPI (Sep. 2024) = 115.7848.

KPC Pharmaceuticals Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201412 0.079 99.000 0.092
201503 0.093 99.900 0.108
201506 0.231 99.500 0.269
201509 0.132 100.500 0.152
201512 0.077 100.600 0.089
201603 0.108 102.200 0.122
201606 0.207 101.400 0.236
201609 0.104 102.400 0.118
201612 0.098 102.600 0.111
201703 0.120 103.200 0.135
201706 0.154 103.100 0.173
201709 0.082 104.100 0.091
201712 0.065 104.500 0.072
201803 0.105 105.300 0.115
201806 0.124 104.900 0.137
201809 0.109 106.600 0.118
201812 0.098 106.500 0.107
201903 0.136 107.700 0.146
201906 0.173 107.700 0.186
201909 0.163 109.800 0.172
201912 0.125 111.200 0.130
202003 0.121 112.300 0.125
202006 0.175 110.400 0.184
202009 0.168 111.700 0.174
202012 0.139 111.500 0.144
202103 0.257 112.662 0.264
202106 0.181 111.769 0.188
202109 0.134 112.215 0.138
202112 0.098 113.108 0.100
202203 0.150 114.335 0.152
202206 0.140 114.558 0.141
202209 0.200 115.339 0.201
202212 0.020 115.116 0.020
202303 0.170 115.116 0.171
202306 0.120 114.558 0.121
202309 0.219 115.339 0.220
202312 0.081 114.781 0.082
202403 0.160 115.227 0.161
202406 0.140 114.781 0.141
202409 0.212 115.785 0.212

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


KPC Pharmaceuticals  (SHSE:600422) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


KPC Pharmaceuticals Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of KPC Pharmaceuticals's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


KPC Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
No. 166 Keyi Road, State New and High-Technology Development Zone, Kunming, Yunnan, CHN, 650106
KPC Pharmaceuticals Inc is a pharmaceutical company which focused on innovative natural botanical drugs in China. Its business scope covers traditional Chinese medicine, chemical medicine, and medicinal circulation. Its products include Panax notoginseng, gastrodine, artemether, and special botanical drugs.
Executives
Qu Xiao Ru senior management
Xie Bo senior management
Meng Li senior management
Zhong Xiang Gang senior management
Wu Sheng Long senior management
Liu Jun Feng senior management
Wang Lei senior management
Zhang Meng Xun senior management
Hu Zhen Bo senior management
Sun Lei senior management
Xu Chao Neng senior management
Wang Jun senior management
Zhao Jian senior management
He Qin Director
Dai Xiao Chang senior management

KPC Pharmaceuticals Headlines

No Headlines